Literature DB >> 28138568

Cancer Prevention: Lessons Learned and Future Directions.

Barbara K Dunn1, Barnett S Kramer1.   

Abstract

In this review, we address selected areas that are central to the state-of-the-art of cancer prevention science. The emphasis on prevention as a viable and critical approach to decreasing cancer mortality has gained traction in recent years, evidenced by its inclusion in the US Vice President's Cancer Initiative (also termed 'Moonshot'). Cancer prevention occurs by arresting, slowing down, or reversing the carcinogenic process before invasion into surrounding tissue or by avoiding or blocking causative exposure. An important challenge is to identify individuals who will benefit most from preventive interventions with the least possible harm. Preventive interventions range from avoiding known carcinogens (e.g., tobacco or asbestos) to intervening with anticarcinogenic strategies (behavioral modifications , such as diet and exercise; medications; nutritional agents; and vaccination against causative agents). Here, we focus on active intervention with measures involving pharmaceutical and immunological agents.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28138568      PMCID: PMC5271581          DOI: 10.1016/j.trecan.2016.11.003

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  135 in total

1.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

Review 2.  Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

Authors:  Asad Umar; Vernon E Steele; David G Menter; Ernest T Hawk
Journal:  Semin Oncol       Date:  2015-09-10       Impact factor: 4.929

Review 3.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

Review 4.  Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.

Authors:  Bindiya Thakkar; Konstantinos N Aronis; Maria T Vamvini; Kelsey Shields; Christos S Mantzoros
Journal:  Metabolism       Date:  2013-02-16       Impact factor: 8.694

5.  Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer.

Authors:  Louise R Howe; Kotha Subbaramaiah; Clifford A Hudis; Andrew J Dannenberg
Journal:  Clin Cancer Res       Date:  2013-08-19       Impact factor: 12.531

6.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors:  W K Hong; S M Lippman; L M Itri; D D Karp; J S Lee; R M Byers; S P Schantz; A M Kramer; R Lotan; L J Peters
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

Review 7.  Vaccines for established cancer: overcoming the challenges posed by immune evasion.

Authors:  Sjoerd H van der Burg; Ramon Arens; Ferry Ossendorp; Thorbald van Hall; Cornelis J M Melief
Journal:  Nat Rev Cancer       Date:  2016-03-11       Impact factor: 60.716

8.  Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.

Authors:  Daniel Medina; Frances Kittrell; Jamal Hill; Yun Zhang; Susan G Hilsenbeck; Reid Bissonette; Powel H Brown
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-27

Review 9.  Immunologic approaches to cancer prevention-current status, challenges, and future perspectives.

Authors:  Malgorzata E Wojtowicz; Barbara K Dunn; Asad Umar
Journal:  Semin Oncol       Date:  2015-11-14       Impact factor: 4.929

Review 10.  Cancer Prevention: Obstacles, Challenges and the Road Ahead.

Authors:  Frank L Meyskens; Hasan Mukhtar; Cheryl L Rock; Jack Cuzick; Thomas W Kensler; Chung S Yang; Scott D Ramsey; Scott M Lippman; David S Alberts
Journal:  J Natl Cancer Inst       Date:  2015-11-07       Impact factor: 13.506

View more
  7 in total

Review 1.  Cancer Immunoprevention: Current Status and Future Directions.

Authors:  Mahsa Keshavarz-Fathi; Nima Rezaei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-02-27       Impact factor: 4.291

Review 2.  The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer.

Authors:  Marijo Bilusic; David J Einstein; Fatima H Karzai; William L Dahut; James L Gulley; Jeanny B Aragon-Ching; Ravi A Madan
Journal:  Urol Clin North Am       Date:  2020-11       Impact factor: 2.241

3.  EBV based cancer prevention and therapy in nasopharyngeal carcinoma.

Authors:  Ya Cao
Journal:  NPJ Precis Oncol       Date:  2017-05-15

Review 4.  Nutrition in Gynecological Diseases: Current Perspectives.

Authors:  Michał Ciebiera; Sahar Esfandyari; Hiba Siblini; Lillian Prince; Hoda Elkafas; Cezary Wojtyła; Ayman Al-Hendy; Mohamed Ali
Journal:  Nutrients       Date:  2021-04-02       Impact factor: 5.717

5.  Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-β Signaling.

Authors:  Sham Jdeed; Máté Lengyel; Iván P Uray
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

Review 6.  Cancer prevention and screening: the next step in the era of precision medicine.

Authors:  Holli A Loomans-Kropp; Asad Umar
Journal:  NPJ Precis Oncol       Date:  2019-01-28

7.  Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer.

Authors:  Yanghee Woo; Vincent Reid; Kaitlyn J Kelly; Diane Carlson; Zhenkun Yu; Yuman Fong
Journal:  Mol Ther Oncolytics       Date:  2019-12-06       Impact factor: 7.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.